Cargando…
Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is the most common kidney malignancy characterized by a poor prognosis. The treatment efficacy of immune checkpoint inhibitors (ICIs) also varies widely in advanced ccRCC. We aim to construct a robust gene signature to improve the prognostic discrimination and...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253123/ https://www.ncbi.nlm.nih.gov/pubmed/34262797 http://dx.doi.org/10.1080/2162402X.2021.1933332 |